Article
Chronic hepatitis C genotype 1 virus: who should wait for treatment?
World journal of gastroenterology - 21 Mar 2014
Tovo Cristiane Valle, de Mattos Angelo Alves, de Almeida Paulo Roberto Lerias
Abstract excerpt
Elucidation of the natural history of chronic hepatitis C (CHC) and the identification of risk factors for its progression to advanced liver disease have allowed many physicians to recommend deferral treatment (triple therapy) in favour of waiting for new drug availability for patients who are at low risk of progression to significant liver disease. Newer generation drugs are currently under development, and are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
